Visionary experiences are profoundly altered states of consciousness characterised by intense, often luminous imagery, feelings of cosmic significance, encounters with non-ordinary entities or presences, and sometimes radical shifts in the sense of identity or reality. They arise across multiple contexts — entheogenic substances, spontaneous mystical events, near-death, deep meditation, and certain pathological states — and share phenomenological features that have attracted both neuroscientific and philosophical attention.
William James identified four marks of the mystical experience in The Varieties of Religious Experience (1902): noetic quality (felt revelation of truth), ineffability (resistance to verbal description), transiency (brevity despite lasting impact), and passivity (the sense that the experience is received rather than willed). These dimensions have informed all subsequent phenomenological research.
Ayahuasca is a botanical preparation combining Banisteriopsis caapi (containing monoamine oxidase inhibitors) with Psychotria viridis or other DMT-containing plants, making oral DMT bioavailable. Used in Amazonian shamanic traditions for centuries as a healing and divination tool, it was introduced to Western scientific attention in the mid-20th century. The Santo Daime and União do Vegetal religious movements, originating in Brazil, use ayahuasca as a sacrament within structured ritual contexts. Contemporary scientific research programmes at institutions in Spain, the United States, and Brazil have examined its neurological, psychological, and therapeutic properties.
Roland Griffiths and colleagues at Johns Hopkins began publishing landmark psilocybin studies from 2006 onward. In a controlled double-blind trial, high-dose psilocybin produced mystical-type experiences in the majority of participants that were rated — at 14-month follow-up — among the most personally meaningful experiences of their lives. Subsequent work established psilocybin's efficacy for reducing existential distress in cancer patients and for treatment-resistant depression, as well as demonstrating measurable reductions in neuroticism and increases in openness as trait personality effects. Research on 5-MeO-DMT (present in certain toads and plants) demonstrated even more reliably complete mystical experience induction at appropriate doses.
Rick Strassman, a psychiatrist at the University of New Mexico, conducted the first federally approved human research with DMT in the United States from 1990 to 1995. In 60 volunteers receiving intravenous DMT in a clinical setting, Strassman documented a striking recurrence of entity encounters — contacts with beings described as insectoid, reptilian, clown-like, or humanoid intelligences that appeared to inhabit the DMT space as independent presences. These encounters, described in DMT: The Spirit Molecule (2001), share structural features with alien abduction reports, near-death experiences, and shamanic spirit contacts across unrelated traditions. Strassman proposed tentatively that DMT might mediate access to a normally imperceptible stratum of reality, though he acknowledged this as speculation. He also investigated the possibility that endogenous DMT, synthesised in the brain, might be involved in near-death and mystical states.
In 1962, theologian and physician Walter Pahnke conducted what became known as the Good Friday Experiment. Seminary students at Boston University attended a two-and-a-half hour Good Friday service after receiving either psilocybin or a nicotinic acid placebo. Nine of ten psilocybin recipients reported profound mystical experiences meeting James's criteria; one of ten placebo recipients reported a comparable experience. A 25-year follow-up by Rick Doblin found that the psilocybin group maintained the significance of the experience and reported persistent positive life changes. This study is considered the template for the current generation of therapeutic psilocybin research.
Entheogenic visionary experiences are primarily mediated by 5-HT2A receptor activation in cortical pyramidal neurons. Neuroimaging studies show that psilocybin and LSD characteristically suppress activity in the default mode network (DMN) — the brain's midline self-referential network — while dramatically increasing functional connectivity between networks that are normally segregated. This "connectome-expanding" effect has been proposed as the neurological basis for ego dissolution: the felt dissolution of the usual boundary between self and world. Entropy of brain activity — the complexity and unpredictability of neural signals — is significantly elevated under psychedelics, a pattern opposite to that seen in disorders of consciousness.
These themes overlap substantially with near-death and out-of-body experience phenomenology, leading some researchers to propose a common neurological or ontological substrate. Whether the entities encountered in DMT states are artefacts of the brain, symbolic projections of the unconscious, or — as some researchers including Strassman and Graham Hancock have proposed — independently existing beings in a non-ordinary domain of reality, remains a fundamental open question.
This page presents documented research and reported phenomena. No claims about validity or mechanism are made by this archive.